Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines Committee
Tóm tắt
Từ khóa
Tài liệu tham khảo
Yancy, 2013, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 62, e147, 10.1016/j.jacc.2013.05.019
Francis, 2010, ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training, J Am Coll Cardiol, 56, 424, 10.1016/j.jacc.2010.04.014
Ammar, 2007, Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community, Circulation, 115, 1563, 10.1161/CIRCULATIONAHA.106.666818
Rose, 2001, Long-term use of a left ventricular assist device for end-stage heart failure, N Engl J Med, 345, 1435, 10.1056/NEJMoa012175
Rogers, 2007, Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTREPID trial, J Am Coll Cardiol, 50, 741, 10.1016/j.jacc.2007.03.063
Hershberger, 2003, Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure, J Card Fail, 9, 180, 10.1054/jcaf.2003.24
Aaronson, 1997, Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation, Circulation, 95, 2660, 10.1161/01.CIR.95.12.2660
Hsich, 2011, Identifying important risk factors for survival in patients with systolic heart failure using random survival forests, Circ Cardiovasc Qual Outcomes, 4, 39, 10.1161/CIRCOUTCOMES.110.939371
Levy, 2006, The Seattle Heart Failure Model: prediction of survival in heart failure, Circulation, 113, 1424, 10.1161/CIRCULATIONAHA.105.584102
Metra, 2007, Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail, 9, 684, 10.1016/j.ejheart.2007.04.003
Stevenson, 2009, INTERMACS profiles of advanced heart failure: the current picture, J Heart Lung Transplant, 28, 535, 10.1016/j.healun.2009.02.015
Stewart, 2012, Mechanical circulatory support for advanced heart failure: patients and technology in evolution, Circulation, 125, 1304, 10.1161/CIRCULATIONAHA.111.060830
Eshaghian, 2006, Relation of loop diuretic dose to mortality in advanced heart failure, Am J Cardiol, 97, 1759, 10.1016/j.amjcard.2005.12.072
Thorvaldsen, 2014, Triage of patients with moderate to severe heart failure: who should be referred to a heart failure center?, J Am Coll Cardiol, 63, 661, 10.1016/j.jacc.2013.10.017
Kittleson, 2003, Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality, J Am Coll Cardiol, 41, 2029, 10.1016/S0735-1097(03)00417-0
Cha, 2007, Response to cardiac resynchronization therapy predicts survival in heart failure: a single-center experience, J Cardiovasc Electrophysiol, 18, 1015, 10.1111/j.1540-8167.2007.00926.x
Setoguchi, 2007, Repeated hospitalizations predict mortality in the community population with heart failure, Am Heart J, 154, 260, 10.1016/j.ahj.2007.01.041
Upadhya, 2015, Heart failure with preserved ejection fraction in the elderly: scope of the problem, J Mol Cell Cardiol, 10.1016/j.yjmcc.2015.02.025
Myers, 2006, Association of functional and health status measures in heart failure, J Card Fail, 12, 439, 10.1016/j.cardfail.2006.04.004
Binanay, 2005, Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial, JAMA, 294, 1625, 10.1001/jama.294.13.1625
Kahwash, 2009, Role of the pulmonary artery catheter in diagnosis and management of heart failure, Heart Fail Clin, 5, 241, 10.1016/j.hfc.2008.12.002
Bittner, 1999, Determining prognosis in congestive heart failure: role of the 6-minute walk test, Am Heart J, 138, 593, 10.1016/S0002-8703(99)70166-3
Cahalin, 1996, The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure, Chest, 110, 325, 10.1378/chest.110.2.325
Mancini, 1991, Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure, Circulation, 83, 778, 10.1161/01.CIR.83.3.778
Peterson, 2003, Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers, J Heart Lung Transplant, 22, 1141, 10.1016/S1053-2498(02)01225-1
Fonarow, 2007, Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure, J Am Coll Cardiol, 49, 1943, 10.1016/j.jacc.2007.02.037
Velibey, 2013, Determination of a predictive cutoff value of NT-proBNP testing for long-term survival in ED patients with acute heart failure, Am J Emerg Med, 31, 1634, 10.1016/j.ajem.2013.08.033
Gheorghiade, 2007, Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial, Arch Intern Med, 167, 1998, 10.1001/archinte.167.18.1998
Singh, 2012, Comparison of renal predictors for in-hospital and postdischarge mortality after hospitalized heart failure, J Cardiovasc Med (Hagerstown), 13, 246, 10.2459/JCM.0b013e3283516767
Levy, 2009, Can the Seattle Heart Failure Model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?, J Heart Lung Transplant, 28, 231, 10.1016/j.healun.2008.12.015
Goda, 2011, Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle Heart Failure Model (SHFM), J Heart Lung Transplant, 30, 1236, 10.1016/j.healun.2011.05.012
Goda, 2011, The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy, J Heart Lung Transplant, 30, 315, 10.1016/j.healun.2010.09.007
O'Connor, 2010, Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score, J Am Coll Cardiol, 55, 872, 10.1016/j.jacc.2009.08.083
Lee, 2003, Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model, JAMA, 290, 2581, 10.1001/jama.290.19.2581
Cohn, 1981, Neurohumoral control mechanisms in congestive heart failure, Am Heart J, 102, 509, 10.1016/0002-8703(81)90739-0
Cohn, 1984, Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure, N Engl J Med, 311, 819, 10.1056/NEJM198409273111303
Cohn, 2000, Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling, J Am Coll Cardiol, 35, 569, 10.1016/S0735-1097(99)00630-0
Francis, 1984, The neurohumoral axis in congestive heart failure, Ann Intern Med, 101, 370, 10.7326/0003-4819-101-3-370
Heywood, 2007, High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database, J Card Fail, 13, 422, 10.1016/j.cardfail.2007.03.011
Damman, 2009, Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease, J Am Coll Cardiol, 53, 582, 10.1016/j.jacc.2008.08.080
Mullens, 2009, Importance of venous congestion for worsening of renal function in advanced decompensated heart failure, J Am Coll Cardiol, 53, 589, 10.1016/j.jacc.2008.05.068
Nikolaou, 2013, Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure, Eur Heart J, 34, 742, 10.1093/eurheartj/ehs332
Lau, 2002, Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation, Am J Cardiol, 90, 1405, 10.1016/S0002-9149(02)02886-2
van Deursen, 2010, Abnormal liver function in relation to hemodynamic profile in heart failure patients, J Card Fail, 16, 84, 10.1016/j.cardfail.2009.08.002
Gelow, 2010, Clinical predictors of hepatic fibrosis in chronic advanced heart failure, Circ Heart Fail, 3, 59, 10.1161/CIRCHEARTFAILURE.109.872556
De, 1998, Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure, J Am Coll Cardiol, 32, 948, 10.1016/S0735-1097(98)00337-4
Di Salvo, 1995, Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure, J Am Coll Cardiol, 25, 1143, 10.1016/0735-1097(94)00511-N
Polak, 1983, Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease, J Am Coll Cardiol, 2, 217, 10.1016/S0735-1097(83)80156-9
Ghio, 2001, Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure, J Am Coll Cardiol, 37, 183, 10.1016/S0735-1097(00)01102-5
Haddad, 2008, Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure, Circulation, 117, 1717, 10.1161/CIRCULATIONAHA.107.653584
Haddad, 2008, Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle, Circulation, 117, 1436, 10.1161/CIRCULATIONAHA.107.653576
Kormos, 2010, Right ventricular failure in patients with the Heartmate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes, J Thorac Cardiovasc Surg, 139, 1316, 10.1016/j.jtcvs.2009.11.020
Kirklin, 2014, Sixth INTERMACS annual report: a 10,000-patient database, J Heart Lung Transplant, 33, 555, 10.1016/j.healun.2014.04.010
Mehra, 2014, Right heart failure: toward a common language, J Heart Lung Transplant, 33, 123, 10.1016/j.healun.2013.10.015
Moraes, 2000, Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management, Circulation, 102, 1718, 10.1161/01.CIR.102.14.1718
Naeije, 2013, The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease, Eur Respir J, 41, 217, 10.1183/09031936.00074312
Fang, 2012, World Health Organization Pulmonary Hypertension Group 2: pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation, J Heart Lung Transplant, 31, 913, 10.1016/j.healun.2012.06.002
Aronson, 2011, Relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure, Circ Heart Fail, 4, 644, 10.1161/CIRCHEARTFAILURE.110.960864
Gerges, 2013, Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in “out-of-proportion” pulmonary hypertension, Chest, 143, 758, 10.1378/chest.12-1653
Herweg, 2008, When is it too late for cardiac resynchronization therapy?, Pacing Clin Electrophysiol, 31, 525, 10.1111/j.1540-8159.2008.01035.x
Noyes, 2013, Cost-effectiveness of cardiac resynchronization therapy in the MADIT-CRT trial, J Cardiovasc Electrophysiol, 24, 66, 10.1111/j.1540-8167.2012.02413.x
Hansky, 2009, Cardiac resynchronization therapy: long-term alternative to cardiac transplantation?, Ann Thorac Surg, 87, 432, 10.1016/j.athoracsur.2008.09.071
Lindenfeld, 2007, Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure, Circulation, 115, 204, 10.1161/CIRCULATIONAHA.106.629261
Herweg, 2007, Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure, Am J Cardiol, 100, 90, 10.1016/j.amjcard.2007.02.058
Konstantino, 2006, Urgent cardiac resynchronization therapy in patients with decompensated chronic heart failure receiving inotropic therapy. A case series, Cardiology, 106, 59, 10.1159/000092616
Carluccio, 2011, Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony, JACC Cardiovasc Imaging, 4, 1067, 10.1016/j.jcmg.2011.07.006
Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399
Stewart, 2010, Patient expectations from implantable defibrillators to prevent death in heart failure, J Card Fail, 16, 106, 10.1016/j.cardfail.2009.09.003
Pettit, 2012, ICDs in end-stage heart failure, BMJ Support Palliat Care, 2, 94, 10.1136/bmjspcare-2011-000176
Lund, 2013, The registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report—2013; focus theme: age, J Heart Lung Transplant, 32, 951, 10.1016/j.healun.2013.08.006
Mancini, 2010, Selection of cardiac transplantation candidates in 2010, Circulation, 122, 173, 10.1161/CIRCULATIONAHA.109.858076
Slaughter, 2013, Heartware ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial, J Heart Lung Transplant, 32, 675, 10.1016/j.healun.2013.04.004
Park, 2012, Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy, Circ Heart Fail, 5, 241, 10.1161/CIRCHEARTFAILURE.111.963991
Thoratec. Available at: www.thoratec.com. Accessed January 28, 2015.
Heartware. Available at: www.heartware.com/about-us/company-profile. Accessed January 28, 2015.
Feldman, 2013, The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary, J Heart Lung Transplant, 32, 157, 10.1016/j.healun.2012.09.013
Slaughter, 2010, Clinical management of continuous-flow left ventricular assist devices in advanced heart failure, J Heart Lung Transplant, 29, S1, 10.1016/j.healun.2010.01.011
Cowger, 2013, Predicting survival in patients receiving continuous flow left ventricular assist devices: the Heartmate II risk score, J Am Coll Cardiol, 61, 313, 10.1016/j.jacc.2012.09.055
Thomas, 2014, Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the Heartmate II risk score, J Heart Lung Transplant, 33, 675, 10.1016/j.healun.2014.02.011
Swetz, 2011, Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy, Mayo Clin Proc, 86, 493, 10.4065/mcp.2010.0747
Decision Memo for Ventricular Assist Devices for Bridge-to-Transplant and Destination Therapy (CAG-00432R). www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=268. Accessed May 12, 2015.
Sindone, 1997, Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy, Am Heart J, 134, 889, 10.1016/S0002-8703(97)80012-9
National Heart Lung and Blood Institute. Incidence and prevalence 2006 chart book on cardiovascular and lung diseases. Bethesda, Maryland: 2006.
National Heart Lung and Blood Institute. National Health and Nutrition Examination Survey 2007–2010. Bethesda, Maryland: 2010.
Go, 2014, Heart disease and stroke statistics–2014 update: a report from the American Heart Association, Circulation, 129, e28, 10.1161/01.cir.0000441139.02102.80
Goldberg, 2005, Incidence and hospital death rates associated with heart failure: a community-wide perspective, Am J Med, 118, 728, 10.1016/j.amjmed.2005.04.013
Barker, 2006, Changing incidence and survival for heart failure in a well-defined older population, 1970–1974 and 1990–1994, Circulation, 113, 799, 10.1161/CIRCULATIONAHA.104.492033
Heidenreich, 2013, Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association, Circ Heart Fail, 6, 606, 10.1161/HHF.0b013e318291329a
Alba, 2013, Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review, Circ Heart Fail, 6, 881, 10.1161/CIRCHEARTFAILURE.112.000043
Bergman, 2007, Frailty: an emerging research and clinical paradigm–issues and controversies, J Gerontol A Biol Sci Med Sci, 62, 731, 10.1093/gerona/62.7.731
Fried, 2001, Frailty in older adults: evidence for a phenotype, J Gerontol A Biol Sci Med Sci, 56, M146, 10.1093/gerona/56.3.M146
Afilalo, 2014, Frailty assessment in the cardiovascular care of older adults, J Am Coll Cardiol, 63, 747, 10.1016/j.jacc.2013.09.070
Dunlay, 2014, Frailty and outcomes after implantation of left ventricular assist device as destination therapy, J Heart Lung Transplant, 33, 359, 10.1016/j.healun.2013.12.014
Flint, 2012, Frailty and the selection of patients for destination therapy left ventricular assist device, Circ Heart Fail, 5, 286, 10.1161/CIRCHEARTFAILURE.111.963215
Rutledge, 2006, Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes, J Am Coll Cardiol, 48, 1527, 10.1016/j.jacc.2006.06.055
Hersh, 2013, Postdischarge environment following heart failure hospitalization: expanding the view of hospital readmission, J Am Heart Assoc, 2, e000116, 10.1161/JAHA.113.000116
Zuccala, 2003, The effects of cognitive impairment on mortality among hospitalized patients with heart failure, Am J Med, 115, 97, 10.1016/S0002-9343(03)00264-X
Allen, 2012, Decision making in advanced heart failure: a scientific statement from the American Heart Association, Circulation, 125, 1928, 10.1161/CIR.0b013e31824f2173
Dunlay, 2012, Living and dying with heart failure: it's time to talk, Eur Heart J, 33, 689, 10.1093/eurheartj/ehr411
Brunner–la Rocca, 2012, End-of-life preferences of elderly patients with chronic heart failure, Eur Heart J, 33, 752, 10.1093/eurheartj/ehr404
Krumholz, 1998, Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments, Circulation, 98, 648, 10.1161/01.CIR.98.7.648
Stevenson, 2008, Changing preferences for survival after hospitalization with advanced heart failure, J Am Coll Cardiol, 52, 1702, 10.1016/j.jacc.2008.08.028
Whellan, 2014, End-of-life care in patients with heart failure, J Card Fail, 20, 121, 10.1016/j.cardfail.2013.12.003
Gelfman, 2014, Engaging heart failure clinicians to increase palliative care referrals: overcoming barriers, improving techniques, J Palliat Med, 17, 753, 10.1089/jpm.2013.0675
Allen, 2008, Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure, JAMA, 299, 2533, 10.1001/jama.299.21.2533
Arnesen, 2003, Quantifying quality of life for economic analysis: time out for time tradeoff, Med Humanit, 29, 81, 10.1136/mh.29.2.81
Torrance, 1987, Utility approach to measuring health-related quality of life, J Chronic Dis, 40, 593, 10.1016/0021-9681(87)90019-1
Lindenfeld, 2010, HFSA 2010 comprehensive heart failure practice guideline, J Card Fail, 16, e1, 10.1016/j.cardfail.2010.04.004
Beernaert, 2013, Referral to palliative care in COPD and other chronic diseases: a population-based study, Respir Med, 107, 1731, 10.1016/j.rmed.2013.06.003
Jaarsma, 2009, Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail, 11, 433, 10.1093/eurjhf/hfp041
Drakos, 2012, Bridge to recovery: understanding the disconnect between clinical and biological outcomes, Circulation, 126, 230, 10.1161/CIRCULATIONAHA.111.040261
Birks, 2006, Left ventricular assist device and drug therapy for the reversal of heart failure, N Engl J Med, 355, 1873, 10.1056/NEJMoa053063
Farrar, 2002, Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function, J Heart Lung Transplant, 21, 516, 10.1016/S1053-2498(01)00408-9
Drakos, 2013, Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery, J Am Coll Cardiol, 61, 1985, 10.1016/j.jacc.2013.01.072
James, 1995, Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure, Circulation, 92, II191, 10.1161/01.CIR.92.9.191
Klotz, 2005, Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness, Circulation, 112, 364, 10.1161/CIRCULATIONAHA.104.515106
Klotz, 2009, The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?, Eur Heart J, 30, 805, 10.1093/eurheartj/ehp012
Drakos, 2010, Myocardial sympathetic innervation and long-term left ventricular mechanical unloading, JACC Cardiovasc Imaging, 3, 64, 10.1016/j.jcmg.2009.10.008
Hall, 2011, Clinical, molecular, and genomic changes in response to a left ventricular assist device, J Am Coll Cardiol, 57, 641, 10.1016/j.jacc.2010.11.010
Ambardekar, 2011, Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects, Circ Heart Fail, 4, 224, 10.1161/CIRCHEARTFAILURE.110.959684
Drakos, 2010, Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart, J Am Coll Cardiol, 56, 382, 10.1016/j.jacc.2010.04.019
Birks, 2005, Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support, Circulation, 112, I57, 10.1161/CIRCULATIONAHA.104.526137
de Jonge, 2002, Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments, J Am Coll Cardiol, 39, 963, 10.1016/S0735-1097(02)01713-8
Hall, 2007, Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy, Eur Heart J, 28, 613, 10.1093/eurheartj/ehl365
Latif, 2007, Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support, J Heart Lung Transplant, 26, 230, 10.1016/j.healun.2006.08.011
Terracciano, 2004, Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy, Circulation, 109, 2263, 10.1161/01.CIR.0000129233.51320.92
Zafeiridis, 1998, Regression of cellular hypertrophy after left ventricular assist device support, Circulation, 98, 656, 10.1161/01.CIR.98.7.656
Mann, 2012, Myocardial recovery and the failing heart: myth, magic, or molecular target?, J Am Coll Cardiol, 60, 2465, 10.1016/j.jacc.2012.06.062
Reed, 2012, In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial), Am J Cardiol, 110, 1150, 10.1016/j.amjcard.2012.05.059
Unroe, 2011, Resource use in the last 6 months of life among Medicare beneficiaries with heart failure, 2000–2007, Arch Intern Med, 171, 196, 10.1001/archinternmed.2010.371
Mulloy, 2013, Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival, J Thorac Cardiovasc Surg, 145, 566, 10.1016/j.jtcvs.2012.10.034
Hernandez, 2008, Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries, JAMA, 300, 2398, 10.1001/jama.2008.716
Rogers, 2012, Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy, Circ Heart Fail, 5, 10, 10.1161/CIRCHEARTFAILURE.111.962951
2004, Special report: cost-effectiveness of left-ventricular assist devices as destination therapy for end-stage heart failure, Technol Eval Cent Assess Program Exec Summ, 19, 1
Ouwens, 2003, The cost effectiveness of lung transplantation compared with that of heart and liver transplantation in the Netherlands, Transpl Int, 16, 123, 10.1111/j.1432-2277.2003.tb00273.x
Feldman, 2005, Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial, J Am Coll Cardiol, 46, 2311, 10.1016/j.jacc.2005.08.033
Acker, 2013, Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States, Circ Heart Fail, 6, e1, 10.1161/HHF.0b013e318279f6b5
Teuteberg, 2013, Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support), JACC Heart Fail, 1, 369, 10.1016/j.jchf.2013.05.006